Anti-C5 antibody treatment for delayed hemolytic transfusion reactions in sickle cell disease

• Aline Floch,
• Alexandre Morel,
• Fabian Zanchetta-Balint,
• Catherine Cordonnier-Jourdin,
• Slimane Allali,
• Maximilien Grall,
• Ghislaine Ithier,
• Benjamin Carpentier,
• Sadaf Pakdaman,
• Jean-Claude Merle,
• Radjiv Goulabchand,
• Tackwa Khalifeh,
• Ana Berceanu,
• Cécile Helmer,
• Christelle Chantalat-Auger,
• Véronique Frémeaux-Bacchi,
• Marc Michel,
• Mariane de Montalembert,
• Armand Mekontso-Dessap,
• France Pirenne,
• Anoosha Habibi,
• Pablo Bartolucci

Affiliations

Aline Floch

Mondor Institute of Biomedical Research, Paris-Est Creteil University, Creteil, France;

Alexandre Morel

French Sickle Cell Referral Center, Henri Mondor Teaching Hospital, Univ Paris Est Creteil, France;

Fabian Zanchetta-Balint

French Sickle Cell Referral Center, Henri Mondor Teaching Hospital, AP-HP, Laboratory of Excellence GR-Ex, INSERM Unit 955, IMRB, Univ Paris Est Creteil, Creteil, France;

Catherine Cordonnier-Jourdin

Pharmacy Department, Henri Mondor Teaching Hospital, AP-HP, France;

Slimane Allali

Department of Pediatrics, Necker Hospital for Sick Children, AP-HP, Laboratory of Excellence GR-Ex, Paris Descartes University, Paris, France;

Maximilien Grall

Department of Internal Medicine, Rouen Teaching Hospital, Rouen, France;

Ghislaine Ithier

Hematology Unit, Reference Centre of Sickle Cell Disease, Robert Debre Hospital, AP-HP, Paris, France;

Benjamin Carpentier

Department of Hematology, Saint Vincent de Paul Hospital, Lille Catholic University, Lille, France;

Sadaf Pakdaman

Etablissement francais du sang Ile de France, INSERM Unit 955, Laboratory of Excellence GR-Ex, IMRB, Univ Paris Est Creteil, Creteil, France;

Jean-Claude Merle

Department of Anesthesia and Surgical Intensive Care-Liver Intensive Care Unit, Henri Mondor Teaching Hospital, AP-HP, Creteil, France;

Radjiv Goulabchand

Department of Internal Medicine-Multiorganic Diseases, Local Referral Center for Autoimmune Diseases, Saint-Eloi Hospital, Montpellier University, Montpellier, France;

Tackwa Khalifeh

Pediatric Medico-surgical Department, Poitiers Teaching Hospital, Poitiers, France;

Ana Berceanu

Intensive Care Hematology Unit, Besancon Teaching Hospital, Besancon, France;

Cécile Helmer

Etablissement francais du sang Auvergne-Rhône Alpes, Grenoble, France;

Christelle Chantalat-Auger

Department of Internal Medicine, Bicetre Teaching Hospital, AP-HP, Universite Paris 11, Le Kremlin-Bicetre, France;

Véronique Frémeaux-Bacchi

Laboratory of Immunology, European Georges Pompidou Hospital, AP-HP, Mixed Health Research Unit INSERM 872, Cordeliers Research Center, Paris, France;

Marc Michel

Department of Internal Medicine, National Referral Center for Immune Cytopenias, Henri Mondor Teaching Hospital, AP-HP, Creteil, France;

Mariane de Montalembert

Department of Pediatrics, Necker Hospital for Sick Children, AP-HP, Laboratory of Excellence GR-Ex, Paris Descartes University, Paris, France;

Armand Mekontso-Dessap

Medical Intensive Care Unit, Henri Mondor Teaching Hospital, AP-HP, Creteil, France

France Pirenne

Etablissement francais du sang Ile de France, INSERM Unit 955, Laboratory of Excellence GR-Ex, IMRB, Univ Paris Est Creteil, Creteil, France;

Anoosha Habibi

French Sickle Cell Referral Center, Henri Mondor Teaching Hospital, AP-HP, Laboratory of Excellence GR-Ex, INSERM Unit 955, IMRB, Univ Paris Est Creteil, Creteil, France;

Pablo Bartolucci

French Sickle Cell Referral Center, Henri Mondor Teaching Hospital, AP-HP, Laboratory of Excellence GR-Ex, INSERM Unit 955, IMRB, Univ Paris Est Creteil, Creteil, France;